Evogene Ltd. plans to list on the Nasdaq Global Market.
The company will delist from the New York Stock Exchange and start trading on Nasdaq on Dec. 30. under the EVGN symbol.
Evogene to list on Nasdaq Global Market
Commercial Banking: June 22nd Edition
Understanding Loss Given Default A Review of Three Approaches
Commercial Banking Newsletter June Edition - 2022
Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push